Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Bronchial Diseases

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Bronchial Diseases in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Bronchial Diseases: Diseases involving the BRONCHI.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Van den Kerckhove, E1
Roosens, L1
Siozopoulou, V1
Verbrugghe, W1
Aerts, J1
Huyskens, J1
Raemen, H1
Jorens, PG1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Bronchial Diseases

ArticleYear
Airway Necrosis and Barotrauma after Ecstasy Inhalation.
    American journal of respiratory and critical care medicine, 2017, Jul-01, Volume: 196, Issue:1

    Topics: Administration, Inhalation; Adult; Bronchi; Bronchial Diseases; Chromatography, Liquid; Hallucinogen

2017